Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation

Urology

Volumn 56, Issue 5, 2000, Pages 833-838

  Burton, Steve ^a,b   Brown, Douglas M ^a,b   Colonias, Athanasios ^a,b   Cohen, Jeffrey ^a,b   Miller, Ralph ^a,b   Rooker, Gina ^a,b   Benoit, Ronald ^a,b   Merlotti, Lori ^a,b   Quinn, Annette ^a,b   Kalnicki, Shalom ^a,b  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CRYOSURGERY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; BIOPSY; CRYOSURGERY; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 0033791864     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00778-0     Document Type: Article

References (32)

1. Cancer statistics, 1999
2. Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma
3. Two year PSA and biopsy results after cryosurgical ablation of the prostate (CSAP) for localized adenocarcinoma of the prostate
4. Cryosurgical ablation of the prostate for localized adenocarcinoma; a preliminary experience
5. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate
6. Cryosurgery as a treatment for prostate carcinoma
7. Prostate cancer; US-guided percutaneous cryoablation, work in progress
8. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate
9. Role of the postradical prostatectomy irradiation in carcinoma of the prostate
10. Residual disease after radical surgery or radiation therapy for prostate cancer; clinical significance and therapeutic implications
11. Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule
12. Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate; ten-year update
13. Radiation therapy following radical prostatectomy
14. Long-term results of radiation therapy for prostate cancer recurrences following radical prostatectomy
15. Effect of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer
16. Consensus statement; guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy
17. Consensus statement; guidelines for PSA following radiation therapy
18. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate; analysis of RTOG studies 7506 and 7706
19. Fifteen-year survival in prostate cancer; a prospective, population-based study in Sweden
20. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy for distinguishing local recurrence from distant metastases
21. Surgical management of prostate cancer; contemporary results with anatomic radical prostatectomy
22. Outcome for lymph node dissection negative T-1b, T-2(A-2, B) prostate cancer treated with external beam irradiation therapy in RTOG 77-06
23. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer
24. Brachytherapy and organ preservation in the management of carcinoma of the prostate
25. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma
26. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
27. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostate carcinoma; a randomized comparative trial of the Radiation Therapy Oncology Group
28. Down-staging of early stage prostate cancer before radical prostatectomy; the first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist
29. Three dimensional conformal radiotherapy for the treatment of prostate cancer; low risk of chronic rectal morbidity observed in a large series of patients
30. Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer
31. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate; interim report of a phase I dose escalation study
32. Conformal technique dose escalation for prostate cancer; chemical evidence of improved cancer control with higher doses in patients with pre-treatment prostate-specific antigen ≥ 10 ng/mL